"Despite claims by pharmaceutical manufacturers that new therapies offset other health care costs, the exorbitant price tags lead to significant increases in health care spending.... Given the significant cost impact associated with the prescription drug pipeline, greater transparency around drug pricing, specifically related to the cost of developing these medications, will help inform policy discussions and solutions for improving patient access to lifesaving treatments."  MORE >>